Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Bridgebio Oncology Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing the pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. Its pipeline of RAS-targeted oncology drug candidates includes BBO-8520, BBO-10203, and BBO-11818. BBO-8520 (NCT06343402) is a direct inhibitor of KRASG12C in both the ON and OFF states that is being evaluated both as monotherapy and in combination with pembrolizumab in the Phase 1 ONKORAS-101 trial for patients with KRASG12C mutant non-small cell lung cancer. BBO-10203 (NCT06625775) is an orally bioavailable small molecule that selectively and specifically blocks the physical interaction between RAS and PI3Ka, resulting in the inhibition of RAS-driven PI3Ka-AKT signaling in tumors without the risk of hyperglycemia. BBO-11818 (NCT06917079) is a panKRAS inhibitor targeting mutant KRAS in both the ON and OFF states with strong potency against KRASG12D and KRASG12V mutants.
Find out what a historical investment in BridgeBio Oncology Therapeutics Inc would be worth today using our BBOT stock calculator.
Buying BBOT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BridgeBio Oncology Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BBOT
What is the ticker symbol of BridgeBio Oncology Therapeutics Inc?
The ticker symbol for BridgeBio Oncology Therapeutics Inc is BBOT.
How much is one share of BBOT?
One share of BBOT is valued at $0.00 as of 20 November 2026.
What is the market capitalisation of BridgeBio Oncology Therapeutics Inc BBOT?
As of 20 November 2026 BridgeBio Oncology Therapeutics Inc has a market cap of $144.85M.
What is the 52-week high for BridgeBio Oncology Therapeutics Inc stock?
The BridgeBio Oncology Therapeutics Inc 52-week high stock price is $14.87.
What is the 52-week low for BridgeBio Oncology Therapeutics Inc stock?
The BridgeBio Oncology Therapeutics Inc 52-week low stock price is $1.79.
Can I buy BBOT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BBOT shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BBOT on Stake
Buy BBOT from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of BBOT from only US$10 with fractional shares